Role of interventional inflammatory bowel disease in the era of biologic therapy: a position statement from the Global Interventional IBD Group.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
02 2019
Historique:
received: 15 07 2018
accepted: 29 09 2018
pubmed: 27 10 2018
medline: 22 5 2019
entrez: 27 10 2018
Statut: ppublish

Résumé

Interventional (or therapeutic) inflammatory bowel disease (IBD) endoscopy has an expanding role in the treatment of disease and surgical adverse events. Endoscopic therapy has been explored and used in the management of strictures, fistulas/abscesses, colitis-associated neoplasia, postsurgical acute or chronic leaks, and obstructions. The endoscopic therapeutic modalities include balloon dilation, stricturotomy, stent placement, fistulotomy, fistula injection and clipping, sinusotomy, EMR, and endoscopic submucosal dissection. With a better understanding of the disease course of IBD, improved long-term impact of medical therapy, and advances in endoscopic technology, we can foresee interventional IBD becoming an integrated part of the multidisciplinary approach to patients with complex IBD.

Identifiants

pubmed: 30365985
pii: S0016-5107(18)33189-4
doi: 10.1016/j.gie.2018.09.045
pii:
doi:

Substances chimiques

Biological Products 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

215-237

Investigateurs

Roger Charles (R)
Yan Chen (Y)
Maria Begoña González Suárez (MB)
Marietta Iaccuci (M)
Tako Kabayashi (T)
Paulo Kotze (P)
Nan Lan (N)
Yue Li (Y)
Ren Mao (R)

Informations de copyright

Copyright © 2019 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Bo Shen (B)

Department of Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, Ohio, USA. Electronic address: shenb@ccf.org.

Gursimran Kochhar (G)

Division of Gastroenterology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.

Udayakumar Navaneethan (U)

Center for Interventional Endoscopy, Florida Hospital, Orlando, Florida, USA.

Xiuli Liu (X)

Department of Pathology and Laboratory Medicines, University of Florida Gainesville, Gainesville, Florida, USA.

Francis A Farraye (FA)

Division of Gastroenterology, Boston Medical Center, Boston, Massachusetts, USA.

Yago Gonzalez-Lama (Y)

Servicio de Gastroenterología y Hepatología, Hospital Universitario Puerta de Hierro, Madrid, Spain.

David Bruining (D)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Darrell S Pardi (DS)

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Martin Lukas (M)

Division of Gastroenerology, lékařská fakulta Univerzity Karlovy, Praha, Czech Republic.

Martin Bortlik (M)

Division of Gastroenerology, lékařská fakulta Univerzity Karlovy, Praha, Czech Republic.

Kaicun Wu (K)

Department of Gastroenterology, Xijin Hospital, Xi'an, China.

Ajit Sood (A)

Department of Gastroenterology, Dayanand Medical College, Ludhiana, India.

David A Schwartz (DA)

Department of Gastroenterology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

William J Sandborn (WJ)

Division of Gastroenterology, University of California San Diego Medical Center, San Diego, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH